Trial intelligence / Profile preview

dTpa Vaccine in Japanese Healthy Pregnant Women

NCT07596199Phase 3Active, not recruiting

Sponsor
GSK
Start
Jun 2026
Primary completion
Nov 2026
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of diphtheria toxoid + tetanus toxoid + acellular pertussis in diphtheria, Tetanus, pertussis, sponsored by GSK. Started Jun 2026; status: active, not recruiting.

02

Drugs

diphtheria toxoid + tetanus toxoid + acellular pertussis
03

Conditions

diphtheriaTetanuspertussis

Beyond the preview

Go deeper on NCT07596199.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07596199.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call